A pair of new enantiomeric neolignans, ethyl 3-[(2R,3S)-2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-7-methoxy-2,3dihydro-1-benzofuran-5-yl] propanoate (+) (1) and ethyl 3-[(2S,3R)-2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-7methoxy-2,3-dihydro-1-benzofuran-5-yl] propanoate (-) (1), together with a pair of known enantiomeric neolignans (+) (2) and (-) (2), as well as five known lignans (3-7) were isolated from the ethanol extract of Lobelia chinensis. Their structures were elucidated on the basis of extensive spectroscopic analyses, including 1D and 2D NMR, HR-ESI-MS and CD spectra.
1 was obtained as colorless oil. Its molecular formula was determined to be C 22 H 26 O 7 by HR-ESI-MS, which showed a quasi-molecular ion at m/z 425.1579 [M + Na + ] (calcd 425.1571). The IR spectrum of 1 showed absorptions for hydroxyl (3498 cm -1 ), ester carbonyl (1725 cm -1 ) and aromatic ring (1608, 1516 cm -1 ). The UV spectrum showed a maximum absorption at Table 1 . The proton signals at δ 5.54 and 3.60, as well as the carbon signals at δ 87.9 and 53.8 were characteristic of dihydrobenzofuran-type neolignans [8] [9] [10] [11] [12] . Comparison of the NMR spectroscopic data of 1 with those of the known compound 3-[2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-7-methoxy-2,3dihydro-1-benzofuran-5-yl]propyl acetate (2) [11, 12] revealed that their NMR signals were very similar, except for some differences at C-9 and C-11. The 1 H-1 H COSY correlations between H-8 and H-9, between H-11 and H-12, as well as the HMBC cross peaks between H 2 -11 and C-10, and between H-9 and C-5 indicated that the presence of a carboxyl and an ethoxyl attached at C-10.
Thus, the planar structure of 1 was assigned and shown in Figure 1 . The relative configuration of 1 could be determined by analysis of its 1 H NMR and ROESY data. In the 1 H NMR spectrum, the coupling constant between H-2 and H-3 was 7.4 Hz, indicating the presence of a trans configuration between H-2 and H-3 [8] [9] [10] [11] [12] [13] , which was further supported by the ROESY correlations between H-2 and H-13, as well as between H-3 and H-2' and H-6'. Despite the presence of two asymmetric carbons at C-2 and C-3, the specific rotation of 1 was almost zero, indicating that 1 was a racemic mixture. For obtaining the corresponding enantiomers, an optical-separation with a chiral HPLC was applied. Finally, (+)-1 ([α] 25 D : +12.2º (c 0.25, CH 3 OH)) and (-)-1 ([α] 25 D : -10.6º (c 0.22, CH 3 OH)) were isolated successfully. The absolute configuration of each enantiomer could be identified by a CD measurement. Compound (+)-1, which showed positive Cotton effects at 235-245 and 285-300 nm, was assigned the (2R, 3S)-configuration according to the reported CD observations of dihydrobenzofuran-type neolignans [8] [9] [10] . Compound (-)-1 exhibited negative Cotton effects at the same spectral ranges and was assigned the (2S, 3R)-configuration. The ratio of (2R, 3S) to (2S, 3R) enantiomer was about 6:4 based on the peak areas in the chiral HPLC. All the available evidence led to the conclusion that (+)-1 and (-)-1 were Compound 2 was obtained as colorless oil. Its formula was determined as C 22 H 26 O 7 from its HR-ESI-MS data (m/z 425.1577 [M + Na + ]), which was identical to those of 1. The IR and UV spectra of 2 were also similar to those of 1, suggested the presence of the same dihydrobenzofuran-type neolignan skeleton in 2. Furthermore, a detailed comparison of the NMR data of 2 ( Table 1) with those of literature values revealed that 2 was a known dihydrobenzofuran-type neolignan, 3-[2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-7methoxy-2,3-dihydro-1-benzofuran-5-yl]propyl acetate [11, 12] . The optical rotation value indicated that 2 was also a racemic mixture. After chiral separation, (+)-2 and (-)-2 were yielded, and their absolute configurations were assigned as (2R, 3S) and (2S, 3R), respectively, based on their CD data.
Compounds 3-7 were respectively identified as (+)pinoresinol (3), (+)-medioresinol (4), (-)-syringaresinol (5), (+)-epipinoresinol (6) , and (-)-episyringaresinol (7) by comparison of their spectroscopic data with those reported in the literatures [13] [14] [15] [16] [17] [18] [19] [20] . To our knowledge, all the above compounds were isolated from the title plant for the first time.
Experimental
General experimental procedures: Optical rotations were measured on a Jasco P-1020 polarimeter with a 2 mm cell. UV spectra were recorded on a Jasco V-550 UV/VIS spectrophotometer. IR spectra were obtained using a Jasco FT/IR-480 Plus spectrometer. CD spectra were measured on an Applied Photophysics Chirascan spectropolarimeter. HR-ESI-MS data were recorded on Neolignans from Lobelia chinensis Natural Product Communications Vol. 5 (10) 2010 1629 an Agilent 6210 ESI-TOF mass spectrometer. 1 H (600 MHz), 13 C (150 MHz), and 2D NMR spectra were recorded on a Bruker AV-600 spectrometer with TMS as internal standard. Column chromatography (CC) was carried out on silica gel (200-300 mesh; Qingdao Marine Chemical Plant), macroporous resin D101 (26-60 mesh; Tianjin Haiguang Chemical Plant), and Sephadex LH-20 (Pharmacia). Preparative HPLC was performed on a Varian Prostar system equipped with a Prostar 325 UV-VIS detector and a reversed-phased column (Cosmosil C 18 -MS-II, 10 × 250 mm, 5 μm). Chiral separation was carried out on a Dionex LC system equipped with a PDA-100 detector and a chiral CD-Ph column (4.6 ×250 mm, 5.0 μm, Shiseido Fine Chemicals Ltd). Subfraction II (3.2 g) was purified by Sephadex LH-20 eluted with CHCl 3 -MeOH (50:50) and then separated by preparative HPLC using MeOH-H 2 O as mobile phase to afford 1 (6.0 mg), 2 (5.3 mg), 3 (12.8 mg), 4 (4.9 mg), 5 (30.3 mg), 6 (11.7 mg), and 7 (7.3 mg). The chiral isolation of 1 (4.6 mg) was performed on a Chiral CD-Ph column at 25ºC and a flow rate of 0.5 mL/min using MeOH-H 2 O (1:1) as mobile phase to afford (+)-1 (1.9 mg) and (-)-1 (1.3 mg). Compound 2 (3.8 mg) was separated using the same chiral column and chromatographic parameters to yield (+)-2 (1.2 mg) and (-)-2 (0.7 mg). 
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